greeksoup/ stock research
Stock research / United States / CLX · Specialty Cleaning, Polishing And Sanitation Preparations · NYSE

Clorox Co. (CLX)

Clorox makes and markets consumer and professional products. It was founded in Oakland, California in 1913, is incorporated in Delaware, has operations in approximately 25 countries or territories and sells in approximately 95 markets. At 30 June 2026 it employed about 9,200 people. Its brands include Clorox cleaning and disinfecting products, Pine-Sol cleaner, Liquid-Plumr clog removers, Poett home care, Glad bags and wraps, Fresh Step cat litter, Kingsford grilling products, Hidden Valley dressings, dips, seasonings and sauces, Brita water filtration and Burt's Bees natural personal care, with Purell, CloroxPro and Clorox Healthcare for professional customers. Over 80% of sales come from brands holding the number one or number two share in their categories.

Clorox Co.

Clorox makes and markets consumer and professional products. It was founded in Oakland, California in 1913, is incorporated in Delaware, has operations in approximately 25 countries or territories and sells in approximately 95 markets. At 30 June 2026 it employed about 9,200 people. Its brands include Clorox cleaning and disinfecting products, Pine-Sol cleaner, Liquid-Plumr clog removers, Poett home care, Glad bags and wraps, Fresh Step cat litter, Kingsford grilling products, Hidden Valley dressings, dips, seasonings and sauces, Brita water filtration and Burt's Bees natural personal care, with Purell, CloroxPro and Clorox Healthcare for professional customers. Over 80% of sales come from brands holding the number one or number two share in their categories.

The four segments

Health and Wellness covers cleaning, disinfecting, sanitizing and professional products sold in the United States, including home care and laundry additives under Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr and Formula 409, skin sanitization under Purell and GOJO, professional cleaning under CloroxPro and Clorox Healthcare, and food service products under Hidden Valley. Household covers Glad bags and wraps, Fresh Step and Scoop Away cat litter and Kingsford grilling products in the United States. Lifestyle covers Hidden Valley food products, Brita water filtration and Burt's Bees personal care in the United States. International covers everything sold outside the country, including laundry additives and home care under Clorox, Poett, Pine-Sol, Clorinda and Chux, Glad bags and wraps, Ever Clean and Fresh Step cat litter and Brita filtration. By product line, cleaning products were 44% of consolidated net sales in fiscal 2026, bags and wraps 15%, food products 11% and cat litter 10%.

GOJO and Glad

In April 2026 the company completed the acquisition of GOJO, adding the Purell brand and GOJO's health and hygiene products. It bought all the issued and outstanding membership interests, and the business now operates as Clorox Purell from northeast Ohio. The company frames the deal as expanding its position in health and hygiene and strengthening its business-to-business presence in healthcare and other institutional markets, through an established distribution network and a large installed base of dispensing systems that generate repeat demand. Separately, the venture agreement with Procter and Gamble covering the Glad bags and wraps business expired on 31 January 2026, and on expiry Clorox was required to buy Procter and Gamble's 20% interest in that business at fair value; Glad keeps the exclusive core intellectual property licences contributed by Procter and Gamble, royalty-free, for the licensed products it markets.

The year and the strategy

The IGNITE strategy rests on four choices: fuelling long-term profitable growth, innovating consumer experiences, reimagining how the company and its people work, and continuously evolving the portfolio, with sustainability integrated across them. The company entered fiscal 2026 implementing and stabilising a new enterprise resource planning system, which created expected near-term disruption. Macroeconomic uncertainty influenced shopping behaviour during the year, slowing categories and lowering sales, and the final phase of the system implementation pulled certain sales into the prior year ahead of consumption, so organic sales and earnings fell. Diluted net earnings per share fell 26% against the prior year, which the company attributes to lower sales and higher manufacturing and logistics costs, partly offset by lapping the loss on the divestiture of the Better Health vitamins, minerals and supplements business. New products during the year included Clorox PURE and Clorox Screen+ Sanitizing Wipes, expanded professional hygiene products from Clorox Healthcare and Purell, Fresh Step Lightweight Litter, Glad ForceFlex MaxStrength LeakGuard trash bags and new Burt's Bees lip and body care.

Selling and supply

In the United States most products are nationally advertised and sold to mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centres, military stores and other retail outlets mainly through a direct sales force, to grocery stores and wholesalers through a mix of direct teams and brokers, and through e-commerce retailers, with some brands sold direct to consumers. Institutional, janitorial, food service and healthcare products go through a direct sales force and brokers to distributors and redistributors. Outside the United States products reach the retail trade through subsidiaries, licensees, distributors and joint ventures with local partners. Raw materials come from numerous unaffiliated suppliers in the United States and abroad, some of them sole or single source, and the key inputs are resins, non-woven fabrics for wipes, sodium hypochlorite, corrugated cardboard, soybean oil, solvent, derivatives of amines and other chemicals and agricultural commodities; they were generally available during fiscal 2026, and price volatility is managed with commodity futures and swaps and long-term supply arrangements.

From Clorox's annual report on Form 10-K for the year ended 30 June 2026. The filing

Compare with another name What $10,000 in Clorox became

Latest results

Latest quarterQ1 FY2027ended 30 September 2026 · 10-Q filed 2 November 2026
Revenue
$1.9 billion
+33.3% on the year · -2.2% on the quarter
Q2 FY2025Q1 FY2027
Net income
$170 million
+112.5% on the year · +4.3% on the quarter
Q2 FY2025Q1 FY2027
Diluted EPS
$1.39
+113.8% on the year · +3.7% on the quarter
Q2 FY2025Q1 FY2027

this quarterthe same quarter a year earlierHover a bar for its figure.

Last full yearFY2026ended 30 June 2026 · 10-K filed 7 August 2026
Revenue
$6.7 billion
-5.4% on the year
FY2019FY2026
Net income
$587 million
-27.5% on the year
FY2019FY2026
Diluted EPS
$4.81
-26.2% on the year
FY2019FY2026

this yearthe year beforeHover a bar for its figure.

The years before, in wordsClorox (CLX) reported revenue of $6.7 billion for fiscal 2026, the year ended 30 June 2026, down 5.4% on the year before. Net income was $587 million and diluted earnings per share $4.81. Revenue was $7.1 billion in fiscal 2025, $7.1 billion in fiscal 2024, $7.4 billion in fiscal 2023 and $7.1 billion in fiscal 2022. Net income in the same years was $810 million, $280 million, $149 million and $462 million. Over the twelve months to 30 September 2026, Clorox reported revenue of $7.2 billion and net income of $677 million. Revenue fell 1.8% a year, compounded, over the five years to fiscal 2026. Clorox declared $4.96 a share in dividends over the last four quarters and had 121 million shares outstanding at the latest filed count. At 30 September 2026 it carried $5.2 billion of debt and $184 million of cash. At the close of 6 November 2026 the market cap of Clorox was $12.1 billion, 18.0 times its earnings over the last twelve months.

Ratios

From the filings

ROEn/a
ROCEn/a
Operating marginn/a
Net margin9.4%
FCF margin6.3%
Interest covern/a
Debt to equityn/a
Cash conversion0.98x
Share count, last 12 months-0.7%
Sales CAGR, 3 years-3.1%
Profit CAGR, 3 years57.9%
EPS, TTM$5.56

At the close of 6 November 2026

Price$99.92
Market cap$12.1 billion
Stock P/E18.0x
Price to bookn/a
EV / EBITDAn/a
Dividend yield5.0%
Market cap / sales1.7x
52-week high$127.16
52-week low$80.41
Price, 1 year-6.0%
Price CAGR, 3 years-9.0%
Price CAGR, 5 years-9.4%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of Clorox Co.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.
CLXgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026 *Q1 FY2027
Revenue1,6911,8091,8011,7401,7151,9152,0191,3861,9901,8141,9031,7621,6861,6681,9881,4291,6731,6701,9481,905
Cost of revenue1,1331,1601,1331,1141,0951,1151,1578541,1241,0481,0199559489241,0648339519481,1441,135
Gross profit558649668626620800862532866766884807738744924596722722804770
Gross margin33%36%37%36%36%42%43%38%44%42%46%46%44%45%46%42%43%43%41%40%
R&D34.031.034.032.033.035.038.029.032.032.033.031.031.027.032.028.029.027.032.029.0
SG&A241233244261282311329276322301268281280267296277262229298290
Interest expense23.021.037.022.023.024.021.021.026.022.021.021.022.023.022.023.025.027.055.052.0
Pre-tax income93.0200129116130-24523729.0136-42.0275177237254410107215256213207
Tax rate23%24%19%25%22%n/a24%14%29%n/a20%42%18%25%18%23%25%25%22%16%
Net income69.015010185.099.0-21117622.093.0-51.021699.019318633280.0157187163170
Net margin4%8%6%5%6%-11%9%2%5%-3%11%6%11%11%17%6%9%11%8%9%
Diluted EPS$0.56$1.21$0.82$0.68$0.80-$1.71$1.42$0.17$0.75-$0.41$1.73$0.80$1.54$1.50$2.68$0.65$1.29$1.54$1.34$1.39
Operating cash flow18122933517820934143020.015318234022118028629493.0311-122330143
Capital expenditure57.063.079.046.042.056.084.024.052.055.081.039.053.053.075.036.042.043.086.038.0
Free cash flow124166256132167285346-4.010112725918212723321957.0269-165244105
Buybacks0.00.00.00.00.00.00.00.00.00.00.01071500.075.01291270.00.00.0
Dividends paid143143143145146146146149149148149151151150150151151150150151
Shares outstanding123m123m123m123m123m124m124m124m124m124m124m124m123m123m123m122m121m121m121m121m
Filing10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2008FY2009 †FY2010 †FY2011FY2012 †FY2013 †FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026TTM
Revenue5,2735,1585,2345,2315,3795,5335,5145,6555,7615,9736,1246,2146,7217,3417,1077,3897,0937,1046,7207,196
Cost of revenue3,0982,9542,9152,9583,1073,1423,1583,1903,1633,3023,4493,4863,6584,1424,5624,4814,0453,8913,8764,178
Gross profit2,1752,2042,3192,2732,2722,3912,3602,4652,5982,6712,6752,7283,0633,1992,5452,9083,0483,2132,8443,018
Gross margin41.2%42.7%44.3%43.5%42.2%43.2%42.8%43.6%45.1%44.7%43.7%43.9%45.6%43.6%35.8%39.4%43.0%45.2%42.3%41.9%
Research and development111113118115121130125136141135132136145149132138126121116117
Selling, general and administrative6907037347357837937517988068108378569691,0049541,1831,1671,1241,0661,079
Interest expense16816113912312512210310088.088.085.097.099.099.010690.090.088.0130159
Pre-tax incomen/an/an/an/an/an/a8849219831,0331,0541,0241,1859006072383981,078791891
Income tax23227432227624327930531533533023120424618113677.0106254190199
Effective tax raten/an/an/an/an/an/a34.5%34.2%34.1%31.9%21.9%19.9%20.8%20.1%22.4%32.4%26.6%23.6%24.0%22.3%
Net income461537603557541572558580648701823820939710462149280810587677
Net margin8.7%10.4%11.5%10.6%10.1%10.3%10.1%10.3%11.2%11.7%13.4%13.2%14.0%9.7%6.5%2.0%3.9%11.4%8.7%9.4%
Diluted EPS$3.23$3.79$4.24$4.02$4.09$4.30$4.23$4.37$4.92$5.33$6.26$6.32$7.36$5.58$3.73$1.20$2.25$6.52$4.81$5.56
Filing10-K10-K10-K10-K8-K8-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Revenue by segment FY2010 to FY2026

FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026Share
of the parts, latest year
Health and Wellnessn/an/an/an/an/an/an/an/an/a2,4222,7492,9802,6902,5322,4852,6972,69740.1%
Household1,6631,6111,6761,6931,7091,7941,8621,9611,9591,7741,7951,9811,9842,0981,9502,0011,78726.6%
Lifestyle8358499019299369509901,0001,0771,0481,1541,2181,2531,3381,2751,3031,12316.7%
International1,1121,1521,1991,1281,0931,0879971,0101,0289701,0231,1621,1801,1811,1621,0651,11316.6%
Cleaning1,6241,6191,6921,7831,7761,8241,9122,0022,060n/an/an/an/an/an/an/an/an/a
Corporate00000n/an/an/an/an/an/an/an/an/an/an/an/an/a
Not assigned to a part in the filingn/an/an/an/an/an/an/an/an/an/an/an/an/a240221n/an/an/a
Sales between segments, taken outn/an/a-89n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Health and Wellness FY2019 to FY2026HouseholdLifestyleInternationalCleaning FY2010 to FY2018
5,231FY20115,514FY20145,973FY20176,721FY20207,149FY20236,720FY2026

$ million; hover a block for its figure and share; the figure over a bar is its parts, before the lines named below; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in. Not assigned to a part in the filing and Sales between segments, taken out are the company's own eliminations and corporate items, which take the parts to revenue: shown as filed, with no share and no block in the chart.

Profit by segment FY2021 to FY2026

The adjusted EBIT each segment reports. Costs Clorox does not charge to a segment are left out, so the segments can add up to more than the company's own adjusted EBIT.

FY2021FY2022FY2023FY2024FY2025FY2026Margin
FY2026
Health and Wellness74838159471984067825.1%
Household37523430826032519210.7%
Lifestyle32028028425329020818.5%
International119978912211011310.2%
Health and WellnessHouseholdLifestyleInternational
1,562FY2021992FY20221,275FY20231,354FY20241,565FY20251,191FY2026

$ million; the figure over a bar is all the segments together. Hover a block for its profit, sales and margin.

FY2026Share of salesShare of profit
Health and Wellness40%57%
Household27%16%
Lifestyle17%17%
International17%9%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an adjusted EBIT figure. A margin is a segment's adjusted EBIT over its own sales.

Revenue by region FY2011 to FY2026, 1 year left out

FY2011FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026Share
of the parts, latest year
United States4,1254,4484,4664,6094,8055,0015,1355,2815,7256,2075,9516,2375,9566,0805,62983.8%
Foreign1,1061,0851,0481,0469569729899339961,1341,1561,1521,1371,0241,09116.2%
United StatesForeign
5,231FY20115,514FY20145,761FY20166,124FY20186,721FY20207,107FY20227,093FY20246,720FY2026

$ million; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

First forecast against the result

Clorox's EPS landed at or above the top of the range in 2, inside it in 1 and under it in 1 of the 4 years shown (FY2016 to FY2019).

+1.9%FY2016−4.1%FY2017+9.4%FY2018−3.1%FY2019
  • At or above the top of the range
  • Inside the range
  • Under the range

Each bar is the year's result against the top of its first forecast range, in per cent of the top. Hover a bar for the figures.

Fiscal yearFirst forecast
EPS
Result
FY2016$4.68 to $4.83$4.92
FY2017$5.38 to $5.58$5.35
FY2018$5.52 to $5.72$6.26
FY2019$6.32 to $6.52$6.32
First forecast
The full-year range the company gave with its fourth-quarter results for the year before, before any later change to it.
Result
The figure the company reported for that year with its next fourth-quarter results.
Years left out
Where the forecast or the result could not be read with confidence. Each figure in the table links to the results release it comes from.

Cash flow

FY2008FY2009 †FY2010 †FY2011FY2012 †FY2013 †FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026TTM
Operating cash flow7307388196986127757678747788659769921,5461,2767861,158695981612662
Capital expenditure170196201228189190137125172231194206254331251228212220207209
Free cash flow5605426184704235856307496066347827861,292945535930483761405453
Free cash flow margin10.6%10.5%11.8%9.0%7.9%10.6%11.4%13.2%10.5%10.6%12.8%12.6%19.2%12.9%7.5%12.6%6.8%10.7%6.0%6.3%
Cash from investing-1,082-197-231544-277-55.0-138-106-430-205-859-196-252-452-229-223-175-94.0-2,301-2,302
Cash from financing380-540-706-1,078-321-685-592-696-316-645-399-815-523-1,391-689-753-655-9241,6681,659
Depreciation and amortisation205188183173178182177169165163166180180211224236235219247265
Share-based compensation47.058.060.032.027.035.036.032.045.051.053.043.050.050.052.073.074.081.048.0n/a
Buybacks868n/a15065522512826043425418327166124890525.00.00.0332256127
Dividends paid228258282303315335368385398412450490533558571583595602602602
Dividend per sharen/a$1.88$2.05$2.25$2.44$2.63$2.87$2.99$3.11$3.24$3.60$3.94$4.29$4.49$3.48$4.72$4.80$4.88$4.96n/a
Diluted shares, weighted141m140m142m138m132m133m132m133m132m132m132m130m128m127m124m124m125m124m122m122m
Shares outstanding at period endn/a139m139m131m130m130m129m129m129m129m128m126m126m123m123m124m124m123m121m121m
Filing10-K10-K10-K10-K8-K8-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2008FY2009 †FY2010 †FY2011FY2012 †FY2013 †FY2014 †FY2015 †FY2016 †FY2017 †FY2018 †FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026TTM
Funded by
Shareholders' equity-370-17583.0-86.0-13514615411829754272655990841155622032832190.0-39.0
Non-controlling interestn/an/an/an/an/an/an/an/an/an/an/an/a0.0181173168164161162160
Debtn/a2,7282,7952,5842,7212,3722,3132,0962,3122,1952,4832,6832,7802,7842,7112,5272,4812,4845,0685,158
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/a278301314310334305366347
Finance lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/a12.015.013.021.021.021.062.0n/a
Other liabilitiesn/a2,0231,6771,6651,7691,7841,7911,9401,9091,8361,8511,8742,2352,6422,3912,6992,4232,2692,0462,206
Total liabilities and equityn/a4,5764,5554,1634,3554,3024,2584,1544,5184,5735,0605,1166,2136,3346,1585,9455,7515,5617,7947,832
Owned
Fixed assets9609419661,0391,0811,0219779189069319961,0341,1031,3021,3341,3451,3151,2671,5121,482
Goodwill1,6581,2841,3031,0701,1121,1051,1011,0671,1971,1961,6021,5911,5771,5751,5581,2521,2281,2291,9451,944
Intangible assetsn/an/an/an/an/an/a611585735722929912894918884712681566n/an/a
Cash and equivalents21420687.0259267299329382401418131111871319183367202167143184
Receivablesn/a486540525576580546519569565600631648604681688695821791745
Inventoryn/a366332382384394386385443459506512454752755696637523777774
Other assetsn/a1,2931,3278889359033082982672822963256668647638859939882,6262,703
Total assetsn/a4,5764,5554,1634,3554,3024,2584,1544,5184,5735,0605,1166,2136,3346,1585,9455,7515,5617,7947,832
Filing10-K10-K10-K10-K8-K8-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded1.6%-1.8%-3.1%6.3%
Profit growth, compounded-1.0%-3.7%57.9%-14.4%
Return on equity, average180.6%228.1%330.0%652.2%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Clorox's revenue in fiscal 2026?

Clorox (CLX) reported revenue of $6.7 billion for fiscal 2026, the year ended 30 June 2026, down 5.4% on the year before.

How much did Clorox earn in fiscal 2026?

Net income was $587 million for fiscal 2026, and diluted earnings per share $4.81.

What is Clorox's P/E ratio?

At the close of 6 November 2026, Clorox traded at 18.0 times its earnings over the twelve months to 30 September 2026.

What is Clorox's market cap?

The market cap of Clorox was $12.1 billion at the close of 6 November 2026.

Does Clorox pay a dividend?

Yes. Clorox declared $4.96 a share in dividends over the four quarters to 30 September 2026.

Peers: Consumer Goods

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
Haleon plc HLN *$40.9 billion18.4310.1%21.9%-1.8%0.522.0%
Estee Lauder Companies Inc. EL$39.9 billion109.019.1%6.7%5.8%1.801.3%
Kenvue Inc. KVUE$37.1 billion21.9416.6%17.4%3.5%0.814.3%
SharkNinja, Inc. SN$31.4 billion37.4126.7%15.6%n/a0.22n/a
Church & Dwight Co. Inc. CHD$25.8 billion33.6417.3%18.0%1.7%0.491.1%
Somnigroup International Inc. SGI$13.5 billion25.6616.5%12.5%27.1%1.371.0%
Clorox Co. CLX$12.1 billion17.97n/an/a6.3%n/a5.0%
A. O. Smith Corp. AOS$8.8 billion17.9727.1%17.5%-0.7%0.372.2%
e.l.f. Beauty, Inc. ELF$6.9 billion80.047.1%8.9%39.9%0.67n/a
Interparfums Inc. IPAR$4.3 billion25.5419.4%17.9%2.6%0.222.4%
Coty Inc. COTY$3.6 billionn/a-18.1%-1.7%-0.2%0.88n/a
Harley-Davidson, Inc. HOG$3.3 billionn/a-4.4%-5.6%-14.6%0.772.3%
All 37 in Consumer Goods
CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
Procter & Gamble Co. PG$383.3 billion24.9129.0%22.6%3.5%0.702.6%
Unilever plc UL *$143.9 billion13.6861.0%17.9%-3.8%1.683.5%
Ecolab Inc. ECL$84.3 billion40.9120.0%16.7%9.3%1.271.0%
Colgate-Palmolive Co. CL$76.7 billion37.86713.2%14.8%5.9%26.792.2%
Haleon plc HLN *$40.9 billion18.4310.1%21.9%-1.8%0.522.0%
Estee Lauder Companies Inc. EL$39.9 billion109.019.1%6.7%5.8%1.801.3%
Kenvue Inc. KVUE$37.1 billion21.9416.6%17.4%3.5%0.814.3%
SharkNinja, Inc. SN$31.4 billion37.4126.7%15.6%n/a0.22n/a
Church & Dwight Co. Inc. CHD$25.8 billion33.6417.3%18.0%1.7%0.491.1%
Somnigroup International Inc. SGI$13.5 billion25.6616.5%12.5%27.1%1.371.0%
Clorox Co. CLX$12.1 billion17.97n/an/a6.3%n/a5.0%
A. O. Smith Corp. AOS$8.8 billion17.9727.1%17.5%-0.7%0.372.2%
e.l.f. Beauty, Inc. ELF$6.9 billion80.047.1%8.9%39.9%0.67n/a
Interparfums Inc. IPAR$4.3 billion25.5419.4%17.9%2.6%0.222.4%
Coty Inc. COTY$3.6 billionn/a-18.1%-1.7%-0.2%0.88n/a
Harley-Davidson, Inc. HOG$3.3 billionn/a-4.4%-5.6%-14.6%0.772.3%
Imax Corp. IMAX$2.6 billion20.6327.3%26.8%28.1%0.50n/a
Whirlpool Corp. WHR$2.0 billionn/a-3.3%2.9%-6.4%1.8417.4%
Stepan Co. SCL$1.5 billion352.580.4%0.9%10.0%0.522.4%
MasterBrand, Inc. MBC$1.4 billionn/a-6.3%-2.0%12.9%0.63n/a
Edgewell Personal Care Co. EPC$1.3 billionn/a-6.4%-0.6%-7.0%0.882.1%
La-Z-Boy Inc. LZB$1.3 billion16.118.0%5.0%0.2%0.002.9%
Apogee Enterprises, Inc. APOG$957 million14.5012.8%7.2%3.0%0.642.3%
Helen of Troy Ltd. HELE$872 millionn/a-11.6%1.3%0.3%0.79n/a
Compass Diversified Holdings CODI$852 millionn/a0.1%6.0%-8.2%3.234.4%
Eastman Kodak Co. KODK$785 millionn/a-13.1%2.5%9.3%0.17n/a
Fox Factory Holding Corp. FOXF$748 millionn/a-72.4%-26.7%-2.2%0.71n/a
Movado Group Inc. MOV$693 million17.248.2%6.9%5.2%0.004.7%
Ethan Allen Interiors Inc. ETD$506 million12.868.5%7.8%-5.7%0.009.0%
Fossil Group, Inc. FOSL$461 millionn/a-77.7%-0.6%-9.1%2.26n/a
Hamilton Beach Brands Holding Co. HBB$432 million7.3226.9%12.6%1.7%0.111.5%
Flexsteel Industries Inc. FLXS$296 million11.5923.6%8.7%3.4%0.001.3%
Traeger, Inc. COOK$189 millionn/a-36.7%-7.9%-25.5%2.86n/a
Bassett Furniture Industries Inc. BSET$188 million27.464.1%2.5%1.4%0.003.7%
GoPro, Inc. GPRO$168 millionn/an/a-21.2%-23.9%n/an/a
Hooker Furnishings Corp. HOFT$156 millionn/an/an/an/a0.004.0%
LiveWire Group, Inc. LVWR$112 millionn/an/a-212.1%33.4%n/an/a
No other company here shares its SEC industry code (Specialty Cleaning, Polishing And Sanitation Preparations); these are the names nearest in size in its wider industry, Consumer Goods, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on CLX

Dividends$602.0 million paid in cash dividends in FY2026
Filings24 in twelve months: 12 current reports (8-K), about 9 regulation FD disclosure; 4 results of operations; 3 officer or director change; 3 other events; 1 material agreement
Planned insider salesno Form 144 notice in twelve months
Options tapeput/call 0.69 by open interest at the 6 November 2026 close; the straddle prices a 5.7% move to 20 November 2026
13F holders1,061 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading0 sales and 3 purchases on Form 4 in twelve months
Congress1 House trade disclosed in six months
Short interest10.3 million shares short, 4.14 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 20262 November 2026EDGAR
10-K30 June 20267 August 2026EDGAR
10-Q31 March 202630 April 2026EDGAR
10-Q31 December 20253 February 2026EDGAR
10-Q30 September 20253 November 2025EDGAR
10-K30 June 20258 August 2025EDGAR
10-Q31 March 20255 May 2025EDGAR
10-Q31 December 20243 February 2025EDGAR
10-Q30 September 202430 October 2024EDGAR
10-K30 June 20248 August 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.